PPAR-γ Activation Alleviates Intestinal Dysfunction and Lactose Malabsorption in Experimental Food Allergy Rats
Nutrients · 2026
DOI: 10.3390/nu18040653 ↗At a glance
Journal article in Nutrients, 2026. Written by Yuyang Hao and 5 co-authors. Institution: College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100080, China. Major MEDLINE topics: PPAR gamma, Food Hypersensitivity, Lactose, Intestinal Absorption. 56 references. The full text is freely available (open access, CC BY 4.0). Funded by: Beijing Technology and Business University, the Cross-Innovation Open Project of Food Flavor and Health, Beijing Technology & Business University.
Abstract (original language)
Background/Objectives: Food allergy-induced intestinal inflammation can impair lactose digestion and absorption by damaging the epithelium, leading to secondary lactase deficiency with no effective treatments. The immunometabolism nuclear receptor PPAR-γ regulates gut epithelial function and nutrient absorption. This study aimed to determine whether PPAR-γ activation can preserve lactose digestion and absorption during allergic inflammation and to elucidate the underlying mechanisms.
Methods
In an ovalbumin-sensitized Brown Norway rat model of food allergy, animals were treated with either the PPAR-γ agonist rosiglitazone or the antagonist GW9662. Lactose absorption was assessed by in vivo lactose tolerance tests (blood glucose monitoring) and intestinal transit measurements. Jejunal tissues were analyzed for lactase gene expression, lactase enzyme activity, and SGLT1/GLUT2 transporter levels.
Results
Allergic rats exhibited reduced weight gain, delayed intestinal transit, and lactose malabsorption (lower blood glucose after lactose challenge), accompanied by sharply decreased jejunal lactase mRNA, enzyme activity, and SGLT1/GLUT2 levels. Rosiglitazone treatment restored intestinal PPAR-γ expression and markedly improved lactose absorption, normalizing the lactose tolerance curve. Rosiglitazone also increased lactase gene expression and enzyme activity, and upregulated SGLT1 levels. In contrast, PPAR-γ inhibition with GW9662 further reduced lactase and transporter levels and failed to improve absorption.
Conclusions
PPAR-γ signaling maintains intestinal lactose digestive capacity of rats during allergic inflammation by sustaining lactase production and monosaccharide transporter expression. Our findings verify an immunometabolism mechanism linking nuclear receptor activation to enhanced nutrient absorption and highlight PPAR-γ agonism as a promising therapeutic strategy to alleviate food allergy-associated lactose malabsorption.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100080, China.
- Key Laboratory of Food Nutrition and Health Evaluation Technology, State Administration for Market Regulation, Beijing 100080, China.
- School of Microbiology, University College Cork, T12 K8AF Cork, Ireland.
- School of Food & Health, Beijing Technology & Business University, Beijing 100048, China.
- School of Science, China Agricultural University, Beijing 100080, China.
ORCID profiles: Yuyang Hao, Sheng Yin, Huilian Che
Funding
- Beijing Technology and Business University
- the Cross-Innovation Open Project of Food Flavor and Health, Beijing Technology & Business University
Cite
APA
Hao, Y., Yao, L., Jin, Y., Yin, S., He, Z., & Che, H. (2026). PPAR-γ Activation Alleviates Intestinal Dysfunction and Lactose Malabsorption in Experimental Food Allergy Rats. Nutrients. https://doi.org/10.3390/nu18040653
Vancouver
Hao Y, Yao L, Jin Y, Yin S, He Z, Che H. PPAR-γ Activation Alleviates Intestinal Dysfunction and Lactose Malabsorption in Experimental Food Allergy Rats. Nutrients. 2026. doi:10.3390/nu18040653
BibTeX
@article{Hao2026,
author = {Hao, Yuyang and Yao, Lu and Jin, Yuxin and Yin, Sheng and He, Zhiwei and Che, Huilian},
title = {PPAR-γ Activation Alleviates Intestinal Dysfunction and Lactose Malabsorption in Experimental Food Allergy Rats},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18040653}
}
EUVIMED